SUBSCRIBE
4 minutes
Andrew Aldridge, partner at Deepbridge Capital, discusses how investments in life sciences can be appealing to many investors as the COVID-19 vaccinations roll out globally. The past twelve months have showcased the importance of medical developments like never before. Innovation in the life s
